, target levels < 1.4 mmol/L (55
mg/dL) are recommended.
Best Practice Statement

24. In a person with diabetes and symptomatic peripheral artery disease:
treatment with single antiplatelet therapy should be used,
treatment with clopidogrel should be considered as ﬁrst choice in
preference to aspirin,
combination therapy with aspirin (75 mg to 100 mg once daily) plus
low dose rivar